Publication | Open Access
LBA83 Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): A multicenter randomized controlled trial
53
Citations
0
References
2023
Year
Surgical OncologyPancreatic CancerLba83 Neoadjuvant ChemotherapyGastrointestinal OncologyMedicinePancreatic SurgerySurgeryResectable Pancreatic CancerCancer TreatmentOncologyRadiation OncologyCancer ResearchMolecular Oncology
No additional data available for this publication yet. Check back later!